Honeywell (HON)
NASDAQIndustrialsConglomeratesSnapshot 2026-09-14
$203.44+1.02%
Close 2026-09-15 · 1-day change
NASDAQIndustrialsConglomeratesSnapshot 2026-09-14
Research Workspace
Put HON beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrial Conglomerates is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain and grow revenue with 3%-6% organic growth in 2026: FY26 revenue guidance $19.8B-$20.0B vs $38.8B-$39.8B target.
View ThesisRevenue is contracting — down about 0% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskHoneywell's growth depends on maintaining and growing revenue with 3%-6% organic growth in 2026. Recent financial performance shows steady revenue growth, with a 4% year-over-year increase in Q2 2026. The stock trades at 11× P/E, below the peer median of 24×. This suggests the market is pricing in more growth than forecasted, indicating expectations look full. A specific risk is the potential for a guidance cut, with a 24% probability of missing outlook. Peer multiples imply a price about 19% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-15. HON is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering HON (as of Sep 2026).
Based on 11 Wall Street analysts offering 12-month price targets for HON in the last 4 months.
Continue this research
Compare HON with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HON Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Industrial Conglomerates — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put HON next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete spin-off of Aerospace Technologies by Q3 2026
Completion of spin-off aligns with management's timeline.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $203.44
The last 12 months of price, then the range of analyst 12-month targets from today’s $203.44.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Complete spin-off of Aerospace Technologies by Q3 2026
Concerns about spin-off may delay completion timeline.
Threatens: Maintain and grow revenue with 3%-4% organic growth in 2026
Future growth guidance disappointment impacts revenue growth outlook.
Advances: Complete spin-off of Aerospace Technologies by Q3 2026
Completion of spin-off aligns with management's growth objectives.
Advances: Achieve adjusted EPS growth of 6%-9% in 2026
EPS surge supports adjusted EPS growth objective.
Advances: Maintain and grow revenue with 3%-4% organic growth in 2026
Stronger order trends support revenue growth objectives.
Advances: Optimize portfolio with divestitures and acquisitions
Acquisition aligns with portfolio optimization objective.
Acquisition aligns with management's portfolio optimization goal.
